|
| WX-671/Mesupron Basic information |
Product Name: | WX-671/Mesupron | Synonyms: | WX-671;WX-671/Mesupron;4-[(2S)-3-[3-[(Hydroxyamino)iminomethyl]phenyl]-1-oxo-2-[[[2,4,6-tris(1-methylethyl)phenyl]sulfonyl]amino]propyl]-1-piperazinecarboxylic acid ethyl ester;Mesupron(WX 671);UPAMOSTAT;HUASEDVYRABWCV-NDEPHWFRSA-N;Mesupron(Upamostat);1-Piperazinecarboxylic acid, 4-[(2S)-3-[3-[(hydroxyamino)iminomethyl]phenyl]-1-oxo-2-[[[2,4,6-tris(1-methylethyl)phenyl]sulfonyl]amino]propyl]-, ethyl ester | CAS: | 590368-25-5 | MF: | C32H47N5O6S | MW: | 629.81 | EINECS: | | Product Categories: | | Mol File: | 590368-25-5.mol | |
| WX-671/Mesupron Chemical Properties |
Boiling point | 761.3±70.0 °C(Predicted) | density | 1.25 | storage temp. | Store at -20°C | solubility | DMSO : ≥ 250 mg/mL (396.95 mM) | pka | 6.99±0.69(Predicted) | form | Solid | color | White to off-white |
| WX-671/Mesupron Usage And Synthesis |
Uses | WX 671 is the oral pro-drug of the active metabolite WX-UK1, a uPA inhibitor. |
| WX-671/Mesupron Preparation Products And Raw materials |
|